Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Publication Information:
      Public Library of Science (PLoS), 2020.
    • Publication Date:
      2020
    • Collection:
      LCC:Medicine
      LCC:Science
    • File Description:
      electronic resource
    • ISSN:
      1932-6203
    • Relation:
      https://doaj.org/toc/1932-6203
    • Accession Number:
      10.1371/journal.pone.0227931
    • Rights:
      Journal Licence: CC BY
    • Accession Number:
      edsdoj.98f905df1f01453ca5fc109dd2593684
  • Citations
    • ABNT:
      PLOS ONE EDITORS. Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis. PLoS ONE, [s. l.], n. 1, p. e0227931, 2020. DOI 10.1371/journal.pone.0227931. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsdoj&AN=edsdoj.98f905df1f01453ca5fc109dd2593684&custid=s8280428. Acesso em: 28 fev. 2020.
    • AMA:
      PLOS ONE Editors. Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis. PLoS ONE. 2020;(1):e0227931. doi:10.1371/journal.pone.0227931.
    • APA:
      PLOS ONE Editors. (2020). Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis. PLoS ONE, 1, e0227931. https://doi.org/10.1371/journal.pone.0227931
    • Chicago/Turabian: Author-Date:
      PLOS ONE Editors. 2020. “Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis.” PLoS ONE, no. 1: e0227931. doi:10.1371/journal.pone.0227931.
    • Harvard:
      PLOS ONE Editors (2020) ‘Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis’, PLoS ONE, (1), p. e0227931. doi: 10.1371/journal.pone.0227931.
    • Harvard: Australian:
      PLOS ONE Editors 2020, ‘Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis’, PLoS ONE, no. 1, p. e0227931, viewed 28 February 2020, .
    • MLA:
      PLOS ONE Editors. “Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis.” PLoS ONE, no. 1, 2020, p. e0227931. EBSCOhost, doi:10.1371/journal.pone.0227931.
    • Chicago/Turabian: Humanities:
      PLOS ONE Editors. “Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis.” PLoS ONE, no. 1 (2020): e0227931. doi:10.1371/journal.pone.0227931.
    • Vancouver/ICMJE:
      PLOS ONE Editors. Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis. PLoS ONE [Internet]. 2020 [cited 2020 Feb 28];(1):e0227931. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsdoj&AN=edsdoj.98f905df1f01453ca5fc109dd2593684&custid=s8280428